Unfolding Mechanism and Fibril Formation Propensity of Human Prion Protein in the Presence of Molecular Crowding Agents.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
13 Sep 2024
Historique:
received: 10 08 2024
revised: 10 09 2024
accepted: 12 09 2024
medline: 28 9 2024
pubmed: 28 9 2024
entrez: 28 9 2024
Statut: epublish

Résumé

The pathological process of prion diseases implicates that the normal physiological cellular prion protein (PrP

Identifiants

pubmed: 39337404
pii: ijms25189916
doi: 10.3390/ijms25189916
pii:
doi:

Substances chimiques

Prion Proteins 0
Amyloid 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Manoj Madheswaran (M)

Department of Environmental, Biological and Pharmaceutical Sciences and Technologies (DISTABiF), Università degli Studi della Campania Luigi Vanvitelli, 81100 Caserta, Italy.

Nataliia Ventserova (N)

Department of Environmental, Biological and Pharmaceutical Sciences and Technologies (DISTABiF), Università degli Studi della Campania Luigi Vanvitelli, 81100 Caserta, Italy.

Gianluca D'Abrosca (G)

Department of Clinical and Experimental Medicine, Università degli Studi di Foggia, 71122 Foggia, Italy.

Giulia Salzano (G)

Department of Neuroscience, Scuola Internazionale Superiore di Studi Avanzati, 34136 Trieste, Italy.

Luigi Celauro (L)

Department of Neuroscience, Scuola Internazionale Superiore di Studi Avanzati, 34136 Trieste, Italy.

Federico Angelo Cazzaniga (FA)

Division of Neurology 5-Neuropathology, Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133 Milan, Italy.

Carla Isernia (C)

Department of Environmental, Biological and Pharmaceutical Sciences and Technologies (DISTABiF), Università degli Studi della Campania Luigi Vanvitelli, 81100 Caserta, Italy.

Gaetano Malgieri (G)

Department of Environmental, Biological and Pharmaceutical Sciences and Technologies (DISTABiF), Università degli Studi della Campania Luigi Vanvitelli, 81100 Caserta, Italy.

Fabio Moda (F)

SSD Laboratory Medicine, Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133 Milan, Italy.

Luigi Russo (L)

Department of Environmental, Biological and Pharmaceutical Sciences and Technologies (DISTABiF), Università degli Studi della Campania Luigi Vanvitelli, 81100 Caserta, Italy.

Giuseppe Legname (G)

Department of Neuroscience, Scuola Internazionale Superiore di Studi Avanzati, 34136 Trieste, Italy.

Roberto Fattorusso (R)

Department of Environmental, Biological and Pharmaceutical Sciences and Technologies (DISTABiF), Università degli Studi della Campania Luigi Vanvitelli, 81100 Caserta, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH